First of all, our results showed that the mRNA expression for the ELAVL1 gene did not differ significantly between COPD patients with eosinophilic inflammation and COPD patients with non-eosinophilic inflammation. This evidence concerns the gene ELAVL1 and chronic obstructive pulmonary disease.